ClinicalTrials.Veeva

Menu

Acupuncture in Pediatrics and Adolescents With Chronic Inflammatory Bowel Diseases

Medical University of Vienna logo

Medical University of Vienna

Status

Active, not recruiting

Conditions

Colitis, Ulcerative
Morbus Crohn

Treatments

Other: Acupuncture
Other: Placebo-Acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT04488198
1773/2018

Details and patient eligibility

About

Chronic inflammatory bowel disease (CIBD) with its prevalence of 2.6 million people in Europe is diagnosed in 25% before the age of 18 years. Early remission is intended to improve child growth, quality of life and reduce psychological comorbidities. Additionally to conventional drugs one third of pediatric CIBD patients use alternative treatment strategies. However, there is a lack of evidence of acupuncture as complementary medicine in pediatric CIBD on the disease activity and inflammation. Therefore, the main aim of this study is to evaluate the effect of acupuncture in children with CIBD on the Pediatric Ulcerative Colitis Activity Index (PUCAI) and the Weighted Pediatric Crohn's Disease Activity Index (sPCDAI), which are non-invasive validated instruments to measure the disease activity. Furthermore, this study aims to investigate the effect of acupuncture on chronic pain, quality of life and parameters of inflammation.

Enrollment

60 estimated patients

Sex

All

Ages

10 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • mild/moderate CIBD
  • stable pharmacological treatment at least for 8 weeks

Exclusion criteria

  • complementary alternative medicine

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 3 patient groups, including a placebo group

Control group
No Intervention group
Description:
20 CIBD patients do not receive acupuncture or placebo-acupuncture.
Acupuncture group
Active Comparator group
Description:
20 CIBD patients receive 8 sessions of acupuncture therapy with 0,3 x 30mm needles (asia-med special number 16).
Treatment:
Other: Acupuncture
Placebo group
Placebo Comparator group
Description:
20 CIBD patients receive 8 sessions of sham acupuncture with placebo-needles 0,3 x 30mm (Streitberger).
Treatment:
Other: Placebo-Acupuncture

Trial contacts and locations

1

Loading...

Central trial contact

Christina Hafner, MD, PhD; Gisela Scharbert, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems